1.
Vera Karamfilova, Yavor Assyov, Iveta Nedeva, Antoaneta Gateva, Irena Ivanova, Nikolay Cherkezov, et al. Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease. Turkish Journal of Gastroenterology [Internet]. 2022 Mar. 1 [cited 2025 Sep. 26];33(3):233-9. Available from: https://tjg.avesjournals.com/index.php/tjg/article/view/4204